1. Shoemaker RH, Monks A, Alley MC, Scudiero DA, Fine DL, McLemore TL: Development of human tumor cell line panels for use in disease-oriented drug screening. Prog Clin Biol Res. 1988, 276: 265-286.
2. Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D: Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst. 1991, 83: 757-766.
3. Grever MR, Schepartz SA, Chabner BA: The National Cancer Institute: cancer drug discovery and development program. Semin Oncol. 1992, 19: 622-638.
4. Stinson SF, Alley MC, Kopp WC, Fiebig HH, Mullendore LA, Pittman AF: Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen. Anticancer Res. 1992, 12: 1035-1053.
5. Monks A, Scudiero DA, Johnson GS, Paull KD, Sausville EA: The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets. Anticancer Drug Des. 1997, 12: 533-541.